Autoimmune hemolytic anemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S; Shyam Patel [2], Irfan Dotani [3]

Overview

Overall, the incidence and prevalence of autoimmune hemolytic anemia are low. This condition affects a very small proportion of the population. Autoimmune hemolytic anemia affects men and women equally. There is no racial predilection for autoimmune hemolytic anemia.

Epidemiology and Demographics

Incidence

The incidence of autoimmune hemolytic anemia overall is estimated to be between 0.8 in 100,000 and 3 in 100,000 per year.^[1]^[2]^[3]
The incidence of warm autoimmune hemolytic anemia is estimated to be between 1.25 in 100,000 and 1.33 in 100,000.^[4]
The incidence of drug-induced hemolytic anemia is 1 in 1,000,000.^[4]

Prevalence

The prevalence of autoimmune hemolytic anemia is 17 in 100,000.^[3]

Age

The incidence of autoimmune hemolytic anemia in children is 0.2 in 100,000.^[3]
The incidence of autoimmune hemolytic anemia is higher in adults that in children.^[2]

Race

Autoimmune hemolytic anemia affects all racial backgrounds equally.

Gender

Autoimmune hemolytic anemia affects men and women equally.

References

↑ Böttiger LE, Westerholm B (1973). “Acquired haemolytic anaemia. I. Incidence and aetiology”. Acta Med Scand. 193 (3): 223–6. PMID 4739592. Unknown parameter |month= ignored (help)
↑ ^2.0 ^2.1 Berentsen S (2015). “Role of Complement in Autoimmune Hemolytic Anemia”. Transfus Med Hemother. 42 (5): 303–10. doi:10.1159/000438964. PMC 4678321. PMID 26696798.
↑ ^3.0 ^3.1 ^3.2 Zanella A, Barcellini W (2014). “Treatment of autoimmune hemolytic anemias”. Haematologica. 99 (10): 1547–54. doi:10.3324/haematol.2014.114561. PMC 4181250. PMID 25271314.
↑ ^4.0 ^4.1 Packman CH (2015). “The Clinical Pictures of Autoimmune Hemolytic Anemia”. Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.

Template:WikiDoc Sources

[1] Böttiger LE, Westerholm B (1973). “Acquired haemolytic anaemia. I. Incidence and aetiology”. Acta Med Scand. 193 (3): 223–6. PMID 4739592. Unknown parameter |month= ignored (help)

[pmid26696798-2] 2.0 ^2.1 Berentsen S (2015). “Role of Complement in Autoimmune Hemolytic Anemia”. Transfus Med Hemother. 42 (5): 303–10. doi:10.1159/000438964. PMC 4678321. PMID 26696798.

[pmid25271314-3] 3.0 ^3.1 ^3.2 Zanella A, Barcellini W (2014). “Treatment of autoimmune hemolytic anemias”. Haematologica. 99 (10): 1547–54. doi:10.3324/haematol.2014.114561. PMC 4181250. PMID 25271314.

[pmid26696800-4] 4.0 ^4.1 Packman CH (2015). “The Clinical Pictures of Autoimmune Hemolytic Anemia”. Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.

[1]

[2]

[3]

[4]